astrazeneca diabetes pill
AstraZeneca produced revolutionary oncology drugs and expanded its diabetes treatments with the purchase of its partner Bristol-Myers Squibbsâ entire diabetes division in 2014. The buyout brought drugs like Byetta (exenatide injection) and Bydureon to AstraZeneca.